The relationship between changes in body components and the risk of nonalcoholic fatty liver disease (NAFLD) is not fully understood. We investigated the effects of body components and subsequent changes on incident NAFLD at follow-up ultrasound scanning in a longitudinal cohort. We included 9967 participants without NAFLD at baseline who underwent serial health examinations. Sex-specific, weight-adjusted skeletal muscle index (SMI_Wt) was used. Mean follow-up duration was 48.5 ± 33.5 months. NAFLD developed in 2395 participants (24.0%). Body composition was measured using bioelectrical impedance analysis. The following baseline body components were significantly associated with incident NAFLD: the lowest and middle SMI_Wt tertiles in the n...
Background: Preliminary evidence suggests that weight loss among obese has differential metabolic ef...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/150618/1/hep41391.pdfhttps://deepblue....
Non alcoholic fatty liver disease (NAFLD) is associated with obesity, diabetes and insulin resistanc...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
Non-alcoholic fatty liver disease (NAFLD) is defined as the condition of fat accumulation in the liv...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholi...
Abstract Weight loss, the most established therapy for nonalcoholic fatty liver disease (NAFLD), is ...
Non-alcoholic fatty liver disease (NAFLD) is defined as the condition of fat accumulation in the liv...
The relationship between rising body mass index (BMI) and prospective risk of non-alcoholic fatty li...
Background & Aims: Adverse muscle composition (MC) (i.e., low muscle volume and high muscle fat)...
Studies exploring the relationship between muscle fat content and non-alcoholic fatty liver disease ...
Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease,...
The effect of sarcopenic visceral obesity on the risk of nonalcoholic fatty liver disease (NAFLD) is...
Context: The relationship between rising body mass index (BMI) and prospective risk of non-alcoholi...
Background: Preliminary evidence suggests that weight loss among obese has differential metabolic ef...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/150618/1/hep41391.pdfhttps://deepblue....
Non alcoholic fatty liver disease (NAFLD) is associated with obesity, diabetes and insulin resistanc...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
Non-alcoholic fatty liver disease (NAFLD) is defined as the condition of fat accumulation in the liv...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholi...
Abstract Weight loss, the most established therapy for nonalcoholic fatty liver disease (NAFLD), is ...
Non-alcoholic fatty liver disease (NAFLD) is defined as the condition of fat accumulation in the liv...
The relationship between rising body mass index (BMI) and prospective risk of non-alcoholic fatty li...
Background & Aims: Adverse muscle composition (MC) (i.e., low muscle volume and high muscle fat)...
Studies exploring the relationship between muscle fat content and non-alcoholic fatty liver disease ...
Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease,...
The effect of sarcopenic visceral obesity on the risk of nonalcoholic fatty liver disease (NAFLD) is...
Context: The relationship between rising body mass index (BMI) and prospective risk of non-alcoholi...
Background: Preliminary evidence suggests that weight loss among obese has differential metabolic ef...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/150618/1/hep41391.pdfhttps://deepblue....
Non alcoholic fatty liver disease (NAFLD) is associated with obesity, diabetes and insulin resistanc...